The biotech industry is well-positioned to thrive, owing to inelastic demand, rapid advancements, and government initiatives. So, quality biotech stocks Regeneron Pharmaceuticals, Inc. (REGN), Biogen Inc. (BIIB), and United Therapeutics Corporation (UTHR) could be worth buying.
According to Data Horizzon Research, the AI in biotechnology market share would grow at a 29.7% CAGR until 2032. The rising adoption of AI technologies in numerous biotechnology applications, such as drug discovery, genomics, and personalized medicine, can be attributed to this tremendous growth.
